Quick Answer
Niagen Bioscience, Inc. reported Research And Development Expense of $6.33 million for the year ending 2025.
- Niagen Bioscience, Inc. showed an increase of +5.2% in Research And Development Expense from 2024 to 2025.
- This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Niagen Bioscience, Inc.'s Research And Development Expense has grown by 4,622.5%.
- Historical annual values: Fiscal year 2025: $6.33 million | Fiscal year 2024: $6.02 million | Fiscal year 2023: $4.96 million | Fiscal year 2022: $4.83 million | Fiscal year 2021: $3.83 million | Fiscal year 2020: $3.42 million | Fiscal year 2019: $4.42 million | Fiscal year 2018: $5.48 million | Fiscal year 2017: $4.01 million | Fiscal year 2016: $2.52 million | Fiscal year 2015: $891.6 thousand | Fiscal year 2014: $513.7 thousand | Fiscal year 2013: $134.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: